Information for "Inotuzumab ozogamicin (Besponsa)"
Jump to navigation
Jump to search
View the protection log for this page.
Basic information
| Display title | Inotuzumab ozogamicin (Besponsa) |
| Default sort key | Inotuzumab ozogamicin (Besponsa) |
| Page length (in bytes) | 3,383 |
| Page ID | 694 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 1 |
| Counted as a content page | Yes |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Andrewc072 (talk | contribs) |
| Date of page creation | 19:58, 3 July 2013 |
| Latest editor | Warner-admin (talk | contribs) |
| Date of latest edit | 00:59, 29 June 2024 |
| Total number of edits | 44 |
| Total number of distinct authors | 6 |
| Recent number of edits (within past 90 days) | 2 |
| Recent number of distinct authors | 1 |